Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | -1.49% | -3.98% | -8.30% |
12/02 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
07/02 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.30% | 2.49Cr | |
+38.69% | 73TCr | |
+34.28% | 60TCr | |
-4.49% | 36TCr | |
+20.24% | 33TCr | |
+2.12% | 28TCr | |
+17.02% | 24TCr | |
+9.31% | 21TCr | |
-5.07% | 21TCr | |
-0.35% | 16TCr |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Transcript : Acasti Pharma Inc. - Special Call